Penn Center for Innovation

Fierce BioTech ranks Penn #8 on the global R&D Institute list

Posted on September 2, 2020 — Jessica Jones Gupta

Many new drugs and diagnostics would never have seen the light of day if it wasn’t for these institutes, and our top 10 are the most prolific when it comes to collabs and research pacts with the life sciences industry, with many big-name scientists and alumni working at biotech spin outs from our leading institutes.

“The University of Pennsylvania (Penn) has over the years become synonymous with a revolutionary new way of treating cancer: CAR-T.

From the work of Carl June, M.D., the Richard W. Vague Professor in Immunotherapy and director of the Center for Cellular Immunotherapies—probably the most famous oncology researcher in the world—and his colleagues at Penn, the organization teamed up with Novartis on a seven-year journey that saw the first approval of a CAR-T drug, now known as Kymriah in certain blood cancers.”

 

Read More on Fierce BioTech

Category: external, news